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Background: Mitochondrial dysfunction is one of the major events responsible for activation of neuronal cell death
pathways during cerebral ischemia. Trace element selenium has been shown to protect neurons in various diseases
conditions. Present study is conducted to demonstrate that selenium preserves mitochondrial functional
performance, activates mitochondrial biogenesis and prevents hypoxic/ischemic cell damage.
Results: The study conducted on HT22 cells exposed to glutamate or hypoxia and mice subjected to 60-min focal
cerebral ischemia revealed that selenium (100 nM) pretreatment (24 h) significantly attenuated cell death induced
by either glutamate toxicity or hypoxia. The protective effects were associated with reduction of glutamate and
hypoxia-induced ROS production and alleviation of hypoxia-induced suppression of mitochondrial respiratory
complex activities. The animal studies demonstrated that selenite pretreatment (0.2 mg/kg i.p. once a day for
7 days) ameliorated cerebral infarct volume and reduced DNA oxidation. Furthermore, selenite increased protein
levels of peroxisome proliferator-activated receptor-γ coactivator 1alpha (PGC-1α) and nuclear respiratory
factor 1 (NRF1), two key nuclear factors that regulate mitochondrial biogenesis. Finally, selenite normalized the
ischemia-induced activation of Beclin 1 and microtubule-associated protein 1 light chain 3-II (LC3-II),
markers for autophagy.
Conclusions: These results suggest that selenium protects neurons against hypoxic/ischemic damage by reducing
oxidative stress, restoring mitochondrial functional activities and stimulating mitochondrial biogenesis.
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Cerebral ischemia/stroke, like other neurodegenerative
diseases, increases destruction of neurons by activating
cascade of events such as glutamate-induced excitotoxi-
city, oxidative stress, protein synthesis inhibition, apop-
tosis, and autophagy etc. Brain is very susceptible to
these events in particular to oxidative stress owing to its
high metabolic rate, presence of high content of polyun-
saturated fatty acids and postmitotic nature of neurons
than most other organs. Increased reactive oxygen spe-
cies (ROS) production disrupts antioxidant defense and
directly impairs mitochondrial homeostasis and energy
production [1-3].* Correspondence: pli@nccu.edu
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reproduction in any medium, provided the orTrace element selenium (Se) has been shown to be im-
portant to human health and associated with several
human diseases including Keshan disease, cancer, virus
infections, male infertility, abnormalities in immune
responses, metabolic and neurological disturbances and
developmental delays [4]. Selenium is an essential com-
ponent of the rare amino acid selenocysteine (Sec) and
is incorporated at the catalytic site of various selenium-
dependant enzymes such as glutathione peroxidase (GPx),
thioredoxin reductases, and one methionine-sulfoxide-
reductase. These selenoenzymes play important roles
in regulating metabolic activity, immune function, anti-
oxidant defense and intracellular redox regulation and
modulation [5,6]. Decreased activities of these selenoen-
zymes caused either by depletion/insufficient levels of
Se or mutation results in exacerbation of neuronal loss
and dysfunction. Likewise, genetic inactivation of allLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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degeneration [7]. Selenium supplementation-dependent
increases in selenoenzyme activity or overexpression of
selenoenzymes, in contrast, ameliorates outcome caused
by endogenous or exogenous stress, hypoxia, trauma and
other neurodegenerative conditions including cerebral
stroke [8-14]. Moreover, selenium modulates several cell
signaling pathways, including activating the mitogen-
activated protein kinase (MAPK), phosphotidylinositol
3-kinase (PI3K)-Akt, and NF-kB pathways [15-17].
Previous studies have demonstrated that selenium sup-
plementation ameliorates hypoxia/ischemia-induced
neuronal death in vitro and in vivo [18,19]. However, it
is not known whether selenium is capable of preserving
mitochondrial function in vitro after glutamate exposure
and whether selenium neuroprotective effect is asso-
ciated with activations of mitochondrial biogenesis regu-
lators and autophagy in mice that are subjected to a
transient focal cerebral ischemia. The present study
investigates the neuroprotective effect of selenium pre-
treatment on glutamate toxicity, hypoxia and ischemic
brain damage, and its association to mitochondrial func-
tion. In addition, we assessed the influence of selenium
on the protein levels of two nuclear transcription factors,
nuclear respiratory factor-1 (NRF1) and peroxisome
proliferator-activated receptor-γ coactivator-1 alpha
(PGC-1α), which regulates mitochondrial biogenesis.
Furthermore, we examined autophagy status by measur-
ing protein levels of Beclin 1 and microtubule-associated
protein 1 light chain 3 (LC3). We found that selenium
pretreatment increased cell viability, decreased cell
death, lowered ROS production and improved mito-
chondrial functional performance after glutamate expos-
ure and/or hypoxia. The effects of selenium are well
translated in animal stroke model. Thus, selenium
reduced infarct volume and suppressed oxidative DNA
damage. In addition, selenium pretreatment increased
levels of mitochondrial biogenesis regulators and
reduced level of autophagy modulators.
Methods
Cell culture, treatment and harvest
Murine hippocampal neuronal HT22 cells were main-
tained in Dulbecco's Modified Eagle Medium (DMEM)/
F12 containing 10% fetal bovine serum (FBS), 2 mM glu-
tamine, and 200 mM streptomycin/penicillin (Invitro-
gen) and then maintained at 90–95% relative humidity
in 5% CO2 at 37 °C. The culture medium was renewed
every 3 days. Cells were treated with 100 nM sodium
selenite (Na2SeO3; Sigma, cat. 214485) prepared in phos-
phate buffered saline (PBS) with 1% BSA; pH 7.6 for
24 h prior exposure to glutamate or hypoxia based on
previous study [20]. Glutamate toxicity was induced by
incubating the cells with 4 mM glutamate and effectswere tested 24 h after exposure. Hypoxia was produced
by bubbling DMEM media with N2 until oxygen falls
below 5% of detectable level in an oxygraph glass cham-
ber (Oroboros Instruments, Austria). The final oxygen
content in the chamber was maintained at
2.5 ± 1.0 nmol/ml [21]. Oxygraph allows continuous
monitoring of oxygen level at very high resolution. After
10 h of hypoxia, cells were plated and transferred to in-
cubator maintained at 90–95% relative humidity in 5%
CO2 at 37 °C to allow reoxygenation. All experiments
were performed in triplicate with at least 2 repetitions.Determination of ROS and mitochondrial
membrane potential
Intracellular ROS (superoxide anion) production and
mitochondrial membrane potential were measured using
dihydroethidium (DHE) and tetramethylrhodamine, me-
thyl ester (TMRM) respectively in selenium-pretreated
cells exposed to glutamate (4 mM) or hypoxia (10 h).
ROS production was measured 24 h or 10 h after glu-
tamate or hypoxia exposure respectively. Briefly, cells
(2x106/ml) were incubated with the DHE (2.5 μM) or
TMRM (100 nM) for 30 min at 37 °C. Cells were
washed, resuspended in PBS and analyzed for fluores-
cence intensity using Fluoromax-4 spectroflorometer
(HORIBA Jobin Yvon Inc, Edison, NJ) at the excitation
and emission wavelengths of 480 nm and 590 nm for
ROS and at the excitation 530 nm and emission 573 nm
for mitochondrial membrane potential respectively. The
florescence recorded was represented as relative inten-
sity (%).Measurements of mitochondrial respiration and
complex activities
Polarographic respiration measurement at different com-
plexes was performed in the presence of 0.5 M ADP to
analyze activity of each complex using multiple
substrate-inhibition protocol [22]. Measurement was
done using a high resolution respirometer (Oxygraph,
Oroboros Instrument) equipped with a peltier thermo-
stat and electromagnetic stirrer at 37 °C. Briefly,
digitonin-permeabilized normal and selenium pretreated
HT22 cells (1x107) were incubated in 2 ml mitochon-
drial respiration medium MiR05 (110 mM sucrose,
0.5 mM EGTA, 3.0 mM MgCl2, 60 mM K-lactobionate,
10 mM KH2PO4, 20 mM Taurine, 20 mM HEPES, 1.0 g/l
BSA, pH 7.1) in a glass chamber. Hypoxia was pro-
duced by bubbling medium with N2 until oxygen falls
below 5% [21] of detectable level (Oroboros Instru-
ments, Austria). After 15 min of hypoxia, chamber was
opened to allow reoxygenation. The following substrates
and inhibitors were used for complex I; glutamate
(10 mM), malate (5 mM) and rotenone (0.5 μM); for
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(2.5 μM), and for complex IV: N,N,N’,N’-tetramethyl-p-
phenylenediamine dihydrochloride (TMPD, 0.5 mM), as-
corbate (2 mM) and potassium cyanide (KCN, 1.0 mM).
The integrity of the outer mitochondrial membrane fol-
lowing digitonin permeabilization was confirmed with
cytochrome C (10 mM). Two hypoxic schemes were
used in the study: 10 h hypoxia in non-permeated and
15 min hypoxia in digitonin permeabilized cells. Hypoxia
of 10 h was sufficient to induce cell death in non-
permeabilized cells whereas permeabilized cells were not
able to endure 10 h of hypoxia. Therefore, hypoxic
period was reduced to 15 min according to our pilot
study.
Experimental animals and groups
A total of 43 male C57BL/6 J mice weighing 25-28 g
were used for the experiments. Animals were pretreated
with saline or sodium selenite (0.2 mg/kg, i.p.) for 7 days
followed by induction of cerebral ischemia. Animals
were subjected to 1 h of ischemia and 5- and 24 h of re-
circulation. Both selenium and saline treated mice
(n = 20 in each group) were divided into sham-operated
(7 each), 1 h of ischemia plus 5- (4 each) and 24 h (9
each) of recirculation. Three mice were excluded due to
unsuccessful occlusion. For surgery, the animals were
fasted overnight with free access to water. Anesthesia
was induced by 3% isoflurane with N2O/O2 (70/30) and
maintained at 1.5% during the operation. The operative
animal procedures were approved by the Institutional
Animal Care and Use Committee (IACUC) at North
Carolina Central University.
Ischemic model
Transient middle cerebral artery occlusion (MCAO) was
induced by the intraluminal filament technique as
described previously [23]. Briefly, the right common ca-
rotid artery (CCA), internal carotid artery (ICA) and ex-
ternal carotid artery (ECA) were exposed through a
midline incision. A filament coated with silicon rubber
(diameter of 0.21 ± 0.02 mm) was inserted into the ICA
through the CCA to occlude the origin of the middle
cerebral artery (MCA). Filament was withdrawn to allow
recirculation after 1 h of MCAO. The core temperature
during surgery was maintained at 37 ± 0.5°C by a heating
blanket. After the occlusion the mice were examined
and only animals with neurological signs of diminished
resistance to lateral push, walking to the left after being
pulled backwards by the tail, or with spontaneous
contralateral circling were included in the study [24].
Upon predetermined end points (5- and 24 h), animals
were euthanized and the brains were either perfusion
fixed with 4% paraformaldehyde or frozen in liquid ni-
trogen for later studies.Measurements of infarct volume
Paraformaldehyde perfusion-fixed brains were sectioned
with vibratome (30 μm thick) and preserved in antifreeze
solution at −20°C until use. Seven coronal brain sections
collected from sham control (n = 3 each group) and 24 h
recirculation (n = 5 each group) from bregma 2.20 mm
to −4.16 mm were selected and stained with propidium
iodide (PI) (Vector Laboratories Inc., Burlingame, CA)
to view nuclear morphology. Neuronal morphology was
also confirmed with NeuN staining by using anti-NeuN
antibody (1:300, mouse monoclonal; Chemicon, Teme-
cula, CA). Images were captured, areas with condensed
nuclei were outlined, and infarct volume was calculated
using the NIH ImageJ software. As described previously,
histo-mophorlogical studies give priority to detect ische-
mic brain damage over 2,3,5-triphenyltetrazolium chlor-
ide (TTC) staining [25].
Fluoro-Jade B staining
Fluoro-Jade B staining was used to confirm neurodegen-
eration on brain section [26]. Briefly, vibratome brain
sections were mounted; air dried on glass slides and
briefly immersed in descending concentration of ethanol
and distilled water. The slides were then transferred to a
solution of 0.06% potassium permanganate (KMnO4) for
15 min and rinsed with water. Slides were then
immersed in 0.001% Fluoro-Jade B solution (Millipore)
in 0.1% acetic acid for 30 min and rinsed with water fol-
lowed by coverslipping with mounting media (Vector
Laboratories Inc. Burlingame CA). Double labeling with
NeuN was performed as per the protocol of the
manufacturer.
Detection of oxidative DNA damage
Vibratome brain sections (30 μm) of animals subjected
to 1 h of ischemia and 24 h of recirculation were used to
detect oxidative DNA damage using anti-8-hydroxy-2-
deoxyguanosine (anti-8-OHdG, 1:1000; ab62623 Abcam,
Cambridge, MA). Sections were incubated overnight
with primary antibody against 8-OHdG. These sections
were then incubated with anti-rabbit IgG (Alexa Fluor
488 1:500, Invitrogen) secondary antibody. The sections
were mounted with Vectashield mounting medium con-
taining DAPI (Vector Laboratories Inc. Burlingame CA)
and scanned using a Nikon laser-scanning confocal
microscope at 400X final magnification. Three micro-
scopic fields per section from dorso-lateral striatum and
the overlying cortex were captured for analysis.
Western blot analysis
Ischemic cortical area (penumbra) was dissected (n = 4
per subgroup) and homogenized. Nuclear and cytosolic
fractions were extracted by a series of centrifugations
[27]. Protein concentration was determined by the
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sample was loaded and run in 4-12% NuPAGE gel (Invi-
trogen). Following electrophoresis and transfer, the mem-
branes were incubated overnight with primary antibodies
against NRF1 (1:500, sc-23624, Santa Cruz), PGC-1α
(1:500, ST1202, Chemicon), Beclin 1 (1:500, sc-11427, Santa
Cruz), LC-3 (1 μg/ml, M115-3 MBL), histone H3 (1:2000,
05–928 Millipore) or β-actin (1:1000, Santa Cruz). The
membranes were incubated with horseradish peroxidase-
conjugated secondary antibodies for 1 h. The immunoblots
were developed using the Pierce ECL Western blotting sub-
strate (Thermo Scientific, Rockford IL). The protein bands
of β-actin or histone 3 (H3) were used as internal loading
controls. The results were presented as ratios of respective
proteins and loading control.
Immunohistochemistry
Brain vibratome sections were washed in TBS/0.1%
TX100 (TBST). The nonspecific binding sites were
blocked with 5% donkey serum in TBST and incubated
overnight with primary antibody against LC-3 (1 μg/ml,
M115-3 MBL) and phospho-dynamin-related protein 1
(pDrp1, 1:1600, Cell Signaling Technology). pDrp1 is
used to demarcate mitochondrial fragmentation [28] and
to determine whether LC3 staining overlaps with pDrp1
positive mitochondria. These sections were then incu-
bated with secondary antibody (Alexa Fluor 488/568Figure 1 Neuroprotective effect of selenium pretreatment against glu
glutamate toxicity and hypoxic cell death. Cell viability was measured 24 h
Selenium pretreatment significantly improved cell survival from glutamate
micrograph of HT22 cells exposed to glutamate (4 mM) and hypoxia/reoxy
viability was calculated using MTT assay and relative cell viability was expre
experiments conducted in triplicate. *P< 0.05, ***P< 0.001 vs. control and
Cont = control and Glu = glutamate.1:500, Invitrogen). The sections were mounted with
mounting medium containing DAPI and scanned under
Nikon laser-scanning confocal microscope at 400X final
magnification. Three microscopic fields per section were
captured and analyzed for positive changes.Statistics
Statistical analysis for significant changes was performed
with the GraphPad Prism statistical software. Multiple
comparisons were analyzed with two-way ANOVA fol-
lowed by Scheffe’s test. All data are given as means ± SD.
*p< 0.05, **p< 0.01, ***p< 0.001 compared with con-
trols and #p< 0.05 & ##p< 0.01, ##p< 0.001 when
comparison was made between respective groups.Results
Selenium prevents glutamate and hypoxia-induced
cell death
Hippocampal HT22 neuronal cells were pretreated with
selenium in the form of selenite (Na2SeO3) 24 h prior to
glutamate or hypoxia exposure. Selenite concentration
about 100 nM, which is within the physiological range
[20], has no effect on cell viability (Figure 1A & 1B).
Cells exposed to 4 mM of glutamate for 24 h reduced
cell survival by> 65%. Selenium pretreatment prevented
glutamate-induced cell death and increased cell survival.tamate toxicity and hypoxia. A. Effect of selenium pretreatment on
or 10/12 h after glutamate and hypoxia/reoxygenation respectively.
toxicity (4 mM) and hypoxia/reoxygenation (10/12 h). B. Representative
genation (10/12 h) with or without selenium pretreatment. Cell
ssed as % of control set at 100%. Data represents means ± SD of 4
#p< 0.05, ###p< 0.001 vs. respective group. Se = selenium,
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survival to 82% after 12 h of reoxygenation. Interestingly,
selenium pretreatment improved cell survival and pre-
vented cells death in HT22 neuronal cells (Figure 1A &
1B). Therefore, cell survival increased from 82 to 95%
after 12 h of reoxygenation.Selenium pretreatment reduces glutamate-induced
ROS production and preserves mitochondrial
membrane potential
To determine whether protective effect shown by selen-
ium is associated with its antioxidant property, we tested
the effect of selenium on ROS production. ROS were
measured in the form of superoxide anions following
glutamate or hypoxia exposure. As shown in Figure 2A,
glutamate treatment significantly (p< 0.01) increased
ROS levels in HT22 cells. The increased production of
ROS is inversely correlated with cell viability (Figure 1).
Interestingly, as hypothesized, selenium pretreatment
not only lowered ROS levels in control but also signifi-
cantly (p< 0.05) reduced ROS level in HT22 cells treated
with glutamate. Similar results were also observed with
hypoxia, where hypoxia significantly (p< 0.01) increased
ROS levels and selenium pretreatment (p< 0.05) reversed
this trend towards normal level (Figure 2B).
To further confirm the beneficial role of selenium, we
measured mitochondrial membrane potential in cellsFigure 2 Selenium pretreatment attenuates ROS production and main
attenuated by selenium pretreatment following glutamate (A) or hypoxic e
anion (which is one component of total ROS) using Dihydroethidium (DHE
pretreated with selenium. C. Selenium pretreatment prevented the fall in m
results were expressed as relative DHE or TMRM intensity % of control set a
***P< 0.001 vs. control, and #P< 0.05 & ###p< 0.001 vs. respective group.treated with selenium and exposed to hypoxia (10 h)
and reoxygenation (1 h). The result revealed that hyp-
oxia affected mitochondrial function and significantly (p
< 0.05) lowered mitochondrial membrane potential.
Interestingly, selenium pretreatment preserved the mito-
chondrial membrane potential and thereby prevented
the potential fall following hypoxic exposure.Selenium preserves mitochondrial respiration and
complex activities
To determine whether the beneficial effect shown by sel-
enium is mediated through mitochondria, we tested
mitochondrial functional performance following hypoxia
by measuring oxygen utilization using complex specific
substrates (Figure 3A). We then calculated the activities
of each mitochondrial respiratory complex from the
difference in oxygen content reduction in the pres-
ence of specific inhibitor (Figure 3B-3D). As shown in
Figure 3B-3D, hypoxia significantly decreased the ac-
tivity of complex I, II + III and IV by 37 (p< 0.01), 65
(p< 0.001), and 24% (p< 0.01), respectively, as compared
to control. Interestingly, selenium pretreatment slightly
increased the activities of these complexes at basal level.
Compared to selenium pretreated control, the complex
I, II + III and IV activities in selenium-treated hypoxia
model only reduced by 5, 45 and 3%, respectively; indi-
cating that selenium pretreatment alleviated the effect oftains mitochondrial membrane potential. ROS production was
xposure (B). ROS production was measured in the form of superoxide
), after 24 h of glutamate or 10 h of hypoxia exposure in HT22 cell
itochondrial membrane potential following hypoxic exposure. The
t 100% and represented as means ± SD. *P< 0.05, **P< 0.01 &
Se = selenium, Cont = control, Hypo= hypoxia and Glu = glutamate.
Figure 3 Selenium pretreatment preserves mitochondrial respiratory chain complex activities following hypoxia. A. A typical recording
of oxygen consumption of digitonin permeabilized cells showing oxygen concentration (blue) and respiration (oxygen flux, red) using multiple
substrates-inhibitor analysis. The activity of each complex was calculated from the difference in reduction in oxygen content in the presence of
specific substrate and specific inhibitor. B-D. Activity of each mitochondrial complex (1, II, +III and IV) indicates the inhibition of hypoxia-
suppressed complex activities by selenium pretreatment. Data represents means ± SD. **P< 0.01, ***P< 0.001 vs. control and ##p< 0.01,
###p< 0.001 vs. respective group. Se = selenium, Cont = control and Hypo= hypoxia. AA, antimycin A; As, ascorbate; Cyto C, cytochrome c; GM,
glutamate and malate; Rot, rotenone; Sc, succinate; TMPD, N,N,N’,N’-tetramethyl-p-phenylenediamine dihydrochloride.
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tivities were either brought back to normal level (com-
plex I and IV) or significantly improved (Complex
II + III) by selenium as compared to non-Se-treated cells.
Selenium pretreatment reduces ischemic brain damage
To finally determine whether the protective effects of selen-
ium observed in in vitro studies can be translated to an
in vivo cerebral stroke model, we treated mice with selen-
ium for 7 days prior inducing transient focal ischemia. We
found that cerebral ischemia induced brain damage in ani-
mals subjected to 1 h of MCAO and 24 h of recirculation.
Brain damage analyzed with propidium iodide (PI) staining
clearly distinguished the infarct area from the healthy
neighboring tissue (Figure 4A). Infarct area displayed
phenotypic differences in the form of severely condensed
nuclei in contrast to smooth rounded nuclear staining in
the non-damaged area. These changes were further con-
firmed by anti-NeuN and Fluoro-Jade B stainings
(Figure 4B & 4C). The result revealed the loss of NeuN
staining and cellular density in the ischemic side of the
brain. Loss of NeuN staining was associated with neurode-
generation as revealed by Fluoro-Jade B staining, suggesting
that neurons were greatly affected morphologically and
spatially following cerebral ischemia in saline treated mice.
Interestingly, selenium pretreatment prevented neuronal
loss as revealed by preserved anti-NeuN staining and nega-
tive Fluoro-Jade B staining.Measurements of infarct volume using anti-NeuN
stained sections revealed that 1 h of MCAO resulted in
damage to nearly one third of the ipsilateral hemisphere
comprised by striatum and some part of overlying cortex
at 24 h of recovery. In contrast, selenium pretreatment
significantly (p< 0.01) reduced the brain damage. There-
fore the infarct volume reduced from 36.4 ± 24.5 to
11.6 ± 5.0% in selenium treated mice as compared to sa-
line control at 24 h of recovery (Figure 4D). These
results clearly indicate the positive role of selenium in
neuroprotection.Selenium pretreatment prevents cerebral ischemia-
induced oxidative DNA damage
As shown in Figure 2, selenium significantly reduced
ROS level after 24 h of glutamate exposure. Therefore,
we determined to study whether cerebral ischemia
induces oxidative DNA damage and whether selenium
has antagonistic effect on DNA oxidation. Very weak 8-
OHdG immunoreactivity was observed in sham-
operated animals (Figure 5A). After 24 h of recirculation,
8-OHdG immunoreactivity was clearly increased and
presented in the nuclei of saline treated mice. In con-
trast, selenium pretreatment significantly reduced the
number of 8-OHdG immunoreactive cells after 24 h of
reperfusion as compared to saline treated mice
(Figure 5B), indicating that antioxidant property shown
Figure 4 Selenium pretreatment reduces ischemic brain damage after one hour of cerebral ischemia followed by recirculation. A.
Propidium iodide nuclear staining depicts the damaged area in contrast to the intact neighboring tissue. B. Microphotographs of NeuN
immunostaining shows the neuronal population in control and ischemic brain area of selenium and saline pretreated mouse. Cerebral ischemia
caused neuronal degeneration at 24 h of recirculation in striatum and some part of overlying cortex in saline treated mice. Selenium
pretreatment, in contrast, restricted the neuronal damage to only striatal area of the brain after 24 h of recirculation. C. Fluoro-Jade B (green) and
NeuN (red) staining confirm the loss of NeuN staining is associated with neurodegeneration. D. Graph shows infarct volume measured after 24 h
of recirculation in both saline and selenium pretreated groups. Selenium pretreatment significantly decreased (p< 0.05) infarct volume at 24 h of
recirculation. Data represents mean± SD. *P< 0.05. Se = selenium and Cont = control. Bar = 100 μm.
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from being oxidized.
Selenium pretreatment stimulates mitochondrial
biogenesis regulators
Selenium pretreatment increases mitochondrial biogen-
esis in vitro (Li and collegues, communicated data).
Therefore, we explored if selenium pretreatment could
increase the levels of mitochondrial biogenesis regula-
tors, NRF1 and PGC-1α, in in vivo stroke model. As
shown in Figure 6, cerebral ischemia significantly
increased the protein levels of PGC-1α in saline treated
animals at 24 h (p< 0.05) of recirculation. Selenium pre-
treatment further increased PGC-1α at control levelsand each time points of recirculation. Therefore, the in-
crease was significant in control and at 5 h of recircula-
tion animals as compared to respective time points of
non-treated group.
Similarly, NRF1, a downstream transcription factor of
PGC-1α, is significantly increased at 5- (p< 0.001) and
24 h (p< 0.001) of recirculation in mice treated with
saline. Selenium pretreatment further increased the
protein level of NRF1 at control and each time points
of recirculation and the increase reached to significant
level at 24 h (p< 0.001) of recirculation. Therefore,
NRF1 significantly increased at control (p< 0.001) and
24 h (p< 0.001) in selenium pretreated group as com-
pared to respective time points in saline treated ones.
Figure 5 Selenium reduces DNA oxidatioin. A. A set of representative anti-8-OHdG immunofluorescent stained images (green) shows decline
in 8-OHdG fluorescence signal at 24 h of recirculation in selenium pretreated as compared to saline treated. Blue color (DAPI) denotes nuclei. B.
Bar graph shows the number of 8-OHdG positive cells per section in the cortex area of the brain. Data are presented as mean± SD. *P< 0.05.
Se = selenium and Cont = control. Bar = 100 μm.
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may be mediated through increasing mitochondrial pro-
tein synthesis and biogenesis.
Selenium treatment normalizes ischemia-activated
autophagy
Cerebral ischemia has been shown to activate autophagy,
a main process involved in clearance of damaged orga-
nelles and debris. The activation of autophagy can be
detected by measurements of Beclin 1 and LC3-II.
Therefore, we examined whether selenium treatment
affects the levels of Beclin 1 and LC3-II following focal
cerebral ischemia. Western analysis of Beclin 1 in cyto-
solic fraction revealed that Beclin 1 level increased at 5-
and peaked at 24 h in saline treated animals (Figure 7A).
The increase at 24 h reached to significant level as com-
pared to control. In selenium pretreated animals, the
protein levels of Beclin 1 were either remained un-
affected or showed slight decrease with increasing time
of recirculation. Therefore, Beclin 1 levels remained
close to baseline as compared to saline treated mice.
LC3, another marker of autophagy, is synthesized as
pro-LC3 and then cleaved by Atg4 protease to LC3-I.
Upon activation of autophagy, LC3-I is conjugated with
phosphatidylethanolamine to form LC3-II, which be-
come structural component of autophagosomes. As
shown in Figure 7A, LC3-II levels significantly increased
after 5 h (p< 0.001) of recovery and then declined to
near baseline level at 24 h in saline treated animals.
Similar trend was also observed in selenium pretreated
animals, however, LC3-II level was significantly lower at
5- (p< 0.001) and 24 h (p< 0.001) of recirculation ascompared to saline-treated animals with respective time
points of recirculation.
These results were further confirmed with immunolo-
calization of LC3 and pDrp1 (Figure 7B). Cerebral ische-
mia increased LC3 staining as compared to control.
Staining also shows the punctated pattern, which indi-
cates the conversion of LC3-I to II following cerebral is-
chemia. Punctated LC3 staining overlapped with pDrp1
staining. Drp1, when phosphorylated, leads to mitochon-
drial fragmentation and fragmented mitochondrial could
lead to increased cellular damage. Therefore, in the
present study the colocalization of pDrp1 and LC3 indi-
cates that fragmented mitochondria may be cleared up
by autophagy dependant mechanisms. Interestingly, as
shown in Figure 7A, selenium pretreatment reduced
LC3 staining following cerebral ischemia, suggesting that
cerebral ischemia activates autophagy in order to clear
the damaged organelles and debris. In contrast, selenium
pretreatment reduces ischemic brain damage and
thereby lowers autophagy activation.
Discussion
Selenium has been known for its beneficial function. In
recent years, accumulated evidence has indicated that
much of the beneficial effect of selenium is attributed to
its antioxidant nature and being a functional component
of selenoproteins including selenoenzymes. Selenium
supplementation has been reported to have positive ef-
fect in various diseases and stress conditions including
Keshan disease, thyroid hormone metabolism, excito-
toxicity, neurodegenerative diseases and cancer [29].
Lifelong low selenium level is associated with
Figure 6 Selenium pretreatment increases protein levels of
mitochondrial biogenesis markers, PGC-1α and NRF1.
Representative Western blot and analysis of PGC-1α and NRF1 in
control, 5- and 24 h of recirculation in saline and selenium
pretreated groups (n = 4 each group). The results were normalized
as relative % of control set at 100%. Data represents mean± SD.
*p< 0.05, and ***p< 0.001 vs control and ##p< 0.01, ###p< 0.001
vs. respective time point. Se = selenium and Cont = control.
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study, we investigated the effect of selenium pretreat-
ment on glutamate toxicity, hypoxic and ischemic brain
injury. Our data show that selenium treatment decreased
cell death and improved cell viability from glutamate
toxicity and hypoxia. The positive effect of selenium is
mediated through lowering ROS production/accumula-
tion, and preserving mitochondrial membrane potential
and mitochondrial functional performance. These
in vitro effects of selenium were positively translated to
in vivo stroke model. Therefore, selenium pretreatment
decreased infarct volume, reduced oxidative DNA dam-
age and showed neuroprotection. Additionally, we
detected the increased protein levels of mitochondrial
biogenesis regulators NRF1 and PGC-1α whereas autop-
hagy modulators Beclin 1 and LC3 significantly
decreased following selenium pretreatment.Cerebral ischemia leads to severe structural and func-
tional loss of neurons in the affected region of the brain.
Our study with NeuN and Fluoro-Jade B staining
revealed that under ischemic conditions selenium pre-
treatment reduced neurodegeneration and neuronal loss,
thereby preserving neuronal integrity. Moreover, selen-
ium pretreatment markedly reduced DNA oxidation fol-
lowing cerebral ischemia. Available evidence suggests
that ischemia/reperfusion induces mitochondrial dys-
function by enhancing ROS generation, leading to the
damage of intracellular proteins, lipids, and DNA
[2,31,32]. Presently, we observed that selenium pretreat-
ment significantly reduced ROS production in our
in vitro model of glutamate toxicity [33] and hypoxia
[18], which may be associated with the selenium-
induced increase in activities of antioxidant enzymes
[12,34]. Likewise, our in vitro study has shown that sel-
enium pretreatment protects mitochondrial functional
performance by preserving mitochondrial membrane po-
tential and the activities of mitochondrial complexes.
These results are in direct correlation with the available
evidence that indicates the important role of selenium in
regulating ATP production and activities of mitochon-
drial respiratory chain complexes [16,35,36]. Thus, it
seems most likely that selenium protects mitochondrial
function and inhibits mitochondria-initiated cell death
pathway, which thereby improves neuro-survival [12].
Additionally, reduction in DNA oxidation observed
presently may be attributed to the anti-oxidative na-
ture of selenium, which under these conditions sig-
nificantly reduced neuronal loss as compared to
normal animals.
Reported evidence suggests that selenium accumulates
mainly in mitochondria and nuclei in rat in vivo pre-
treatment trials [37] and also present as the crucial com-
ponent in selenoproteins. Deficiency of selenium or
mutation in selenoenzymes such as glutathione peroxid-
ase (GPx) decreases the expression or activity of these
enzymes [9] and may exacerbate neuronal loss, whereas
selenium pretreatment-dependent increase in activity or
overexpression of selenoenzymes ameliorates outcome
during endogenous or exogenous stimuli, trauma and
other neurodegenerative conditions including cerebral
stroke [10-14].
Selenium has been shown to protect mitochondrial
function by upregulating mitochondrial biogenesis
[12,37,38]. Cerebral ischemia on the other hand is
known to damages mitochondria, increases ROS pro-
duction and impairs ATP generation. Neurons in these
conditions initiate adaptive response through activation
of mitochondrial biogenesis [39]. Therefore, in the
present study we analyzed the protein markers of mito-
chondrial biogenesis (PGC-1α and NRF1). We found
the increased protein levels of PGC-1α and NRF1 at 5-
Figure 7 Selenium pretreatment alters autophagy activation following cerebral ischemia. A. Representative Western blot and analysis of
autophagy markers Beclin 1 and LC3 shows that selenium pretreatment lowers that intensity Beclin 1 and LC3-II as compared to saline treatment.
B. Immunolocalization of LC3 (green) and pDrp1 (red) indicates that cerebral ischemia leads to conversion of LC3-I (diffused) to LC3-II (punctated).
Punctated LC3 pattern overlaps with pDrp1 staining. Selenium pretreatment, on contrary, decreases LC3-II (punctated) staining. The western
results were normalized as relative % of control set at 100% (n = 4 each group). Data represents mean± SD. *p< 0.05, and ***P< 0.001 vs control
and ##p< 0.01, ###p< 0.001 vs. respective time point. Se = selenium and Cont = control. Bar = 100 μm.
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http://www.biomedcentral.com/1471-2202/13/79and/or 24 h of recirculation. These results are in ac-
cordance with the reports that showed marked increase
in mitochondrial DNA content, mitochondrial proteins
and numbers, and mRNA levels of NRF1 and Tfam
after hypoxia and ischemia [40,41]. Interestingly, selen-
ium pretreatment increased the protein levels of PGC-
1α and NRF1 at basal level and increased further after
cerebral ischemia and recirculation as compared to re-
spective control. Previous reports have also shown that
selenite supplementation increased the level of NRF1,
which clearly support our result that mitochondrial bio-
genesis could be modulated by selenite application [42].
In a parallel study (Li and collegues, unpublished data),
we have observed that selenium increases mitochondrial
biogenesis markers and mitochondrial proteins cyto-
chrome c and COX IV under normal culture condition,
inhibits mitochondrial fission induced by glutamate ex-
posure, and induces phosphorylations of Akt, PKA and
CREB, transcription factors that are known to activate
mitochondrial biogenesis. Thus, selenium induced mito-
chondrial biogenesis could be an important strategy toimprove mitochondrial function in various stress condi-
tions including neurodegenerative diseases. In fact, our
in vitro hypoxic study demonstrated that selenium
increased mitochondrial oxidative phosphorylation and
ameliorated the hypoxia-induced suppression to respira-
tory complex activity.
Autophagy is a major catabolic contributor to degrade
and recycle macromolecules and organelles. We and
others have found that autophagy markers Beclin 1 and
LC3-II were increased following cerebral ischemia
[25,43]. Autophagy activation following cerebral ische-
mia is a process to recycle injured cells or a process re-
sponsible for cell demise [43-45]. Interestingly, selenium
pretreatment reduced the protein level of Beclin 1 and
LC3-II cleavage. It has been reported that ROS is a
major factor involved in activation of autophagy [46,47]
and selenium lowers ROS production and prevents
mitochondrial dysfunction [34,48]. Therefore, it is pos-
sible that selenium preserve mitochondrial function,
lowers ROS production, reduces autophagy and thereby
provides neuroprotection.
Mehta et al. BMC Neuroscience 2012, 13:79 Page 11 of 12
http://www.biomedcentral.com/1471-2202/13/79Conclusions
Our results indicate that selenium pretreatment within
the physiological dosage attenuates glutamate toxicity
and hypoxia-induced cell damage in vitro and amelio-
rates ischemic brain injury in vivo. The selenium-
dependant neuroprotective effect may be mediated
through lowering ROS production, preventing DNA oxi-
dation, preserving mitochondrial membrane potential
and mitochondrial functional performance, activating
mechanisms that stimulate mitochondrial biogenesis and
inhibiting autophagy activation. These results therefore
highlight the promising therapeutic potential of selen-
ium against glutamate toxicity, hypoxic and ischemic
brain damage.
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